Physician
Nephrology Associates of Upland and Pomona
Nephrology Associates of Upland and Pomona was paid $5.57M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 90960, End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits — 43% of everything it billed.
33Billing provider infoNEPHROLOGY ASSOCIATES OF UPLAND AND POMONA
UPLAND, CA 91786
UPLAND, CA 91786
33aNPI1982631222assigned 06/26/2006
33bProvider typeNephrology Physician
28Total paid$5.57M
24GClaims100,678
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Nephrology Physician providers in California
Rank by total paid#3 of 363
Median peer was paid$80K
This provider vs. median70×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,433 | $708K | |
| 2019 | 15,301 | $823K | |
| 2020 | 13,054 | $844K | |
| 2021 | 13,156 | $781K | |
| 2022 | 12,067 | $623K | |
| 2023 | 17,613 | $840K | |
| 2024incomplete | 17,054 | $948K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 43% | 21,576 | 21,484 | $2.42M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 24% | 43,557 | 14,413 | $1.34M |
| 36902 | 9.3% | 1,146 | 1,109 | $518K | |
| 99223 | Prolong inpt eval add15 m | 4.4% | 4,397 | 4,250 | $243K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.4% | 7,948 | 7,857 | $190K |
| 36901 | 2.9% | 894 | 868 | $163K | |
| 75710 | 1.8% | 1,737 | 1,620 | $102K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.8% | 3,858 | 1,572 | $99K |
| 36903 | 1.4% | 28 | 28 | $79K | |
| 36215 | 1.1% | 1,247 | 1,157 | $63K | |
| 99152 | <1% | 1,916 | 1,834 | $44K | |
| 36589 | <1% | 503 | 491 | $40K |
24 more codes
| 36905 | <1% | 62 | $38K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 719 | $34K |
| 37248 | <1% | 61 | $29K | |
| 36907 | <1% | 129 | $28K | |
| 36581 | <1% | 302 | $27K | |
| 77001 | <1% | 800 | $27K | |
| J2997 | Injection, alteplase recombinant, 1 mg | <1% | 163 | $20K |
| 90961 | <1% | 136 | $14K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 4,582 | $10K |
| 99454 | <1% | 571 | $8K | |
| 90966 | <1% | 48 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 412 | $6K |
| 99457 | <1% | 585 | $4K | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 1,220 | $3K |
| 99490 | Ccm add 20min | <1% | 410 | $3K |
| 36558 | <1% | 40 | $3K | |
| 99439 | <1% | 230 | $2K | |
| 99458 | <1% | 169 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 283 | $963.50 |
| 76937 | <1% | 46 | $608.89 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 32 | $371.07 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 444 | $196.65 |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | <1% | 414 | $0.03 |
| 6030F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENG, MARGARET (MANAGER)